Hemato Oncology Testing Market Size, Share & Trends Report

Hemato Oncology Testing Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Services), By Cancer Type (Leukemia, Lymphoma, MPNs), By Technology, By End-use, By Region, And Segment Forecasts, 2020 - 2027

  • Published Date: Oct, 2020
  • Base Year for Estimate: 2019
  • Report ID: GVR-4-68039-174-2
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2018
  • Number of Pages: 142

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market segmentation & scope
                   1.2 Market definition
                   1.3 Information procurement
                       1.3.1 Purchased Database
                       1.3.2 GVR’s Internal Database
                       1.3.3 Secondary Sources & Third Party Perspectives
                       1.3.4 Primary Research
                   1.4 Information analysis
                       1.4.1 Data Analysis Models
                   1.5 Market formulation & data visualization
                   1.6 Data validation & publishing
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                   2.3 Competitive Insights
Chapter 3 Hemato Oncology Testing Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent market outlook
                       3.1.2 Ancillary market outlook
                   3.2 Penetration and Growth Prospect Mapping
                       3.2.1 User perspective analysis
                           3.2.1.1 Consumer behavior analysis
                   3.3 Regulatory Framework
                       3.3.1 Reimbursement framework
                       3.3.2 Standards and compliances
                   3.4 Market Dynamics
                       3.4.1 Market driver analysis
                           3.4.1.1 Increasing prevalence of lymphoma & myeloma
                           3.4.1.2 Growing demand for personalized therapy
                           3.4.1.3 Availability of advanced molecular techniques for hemato-oncology diagnostics
                           3.4.1.4 Increasing drug-diagnostics co-development
                       3.4.2 Market restraint analysis
                           3.4.2.1 Unfavorable reimbursement scenario
                       3.4.3 Market opportunities analysis
                           3.4.3.1 Developing countries provide untapped markets for multinational players
                       3.4.4 Market challenges analysis
                           3.4.4.1 Intellectual property rights protection issues
                   3.5 Hemato Oncology Testing Market Analysis Tools
                       3.5.1 INDUSTRY ANALYSIS - PORTER’S
                           3.5.1.1 Supplier Power
                           3.5.1.2 Buyer Power
                           3.5.1.3 Substitution Threat
                           3.5.1.4 Threat from new entrants
                           3.5.1.5 Competitive Rivalry
                       3.5.2 PESTEL ANALYSIS
                           3.5.2.1 Political Landscape
                           3.5.2.2 Environmental Landscape
                           3.5.2.3 Social landscape
                           3.5.2.4 Services landscape
                           3.5.2.5 Legal Landscape
                       3.5.3 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
                           3.5.3.1 Joint ventures
                           3.5.3.2 Mergers and acquisitions
                           3.5.3.3 Licensing and partnership
                           3.5.3.4 Services collaborations
                           3.5.3.5 Strategic Divestments
Chapter 4 Hemato Oncology Testing Market - Competitive Analysis
                   4.1 Recent Developments & Impact Analysis, by Key Market Participants
                   4.2 Company Categorization
                       4.2.1 List of key distributors and channel partners
                       4.2.2 Key company market share analysis, 2019
                   4.3 Public Companies
                       4.3.1 Company market position analysis
                   4.4 Private Companies
                       4.4.1 List of key emerging companies
                       4.4.2 Regional network map
                       4.4.3 Company market position analysis
Chapter 5 Hemato Oncology Testing Market: Cancer Type Estimates and Trend Analysis
                   5.1 Definition & Scope
                   5.2 Cancer Type Market Share Analysis, 2019 & 2027
                   5.3 Segment Dashboard
                   5.4 Global Hemato Oncology Testing Market, by Cancer Type, 2016 to 2027
                   5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
                   5.6 Leukemia
                       5.6.1 Leukemia Market, 2016 To 2027 (USD Million)
                           5.6.1.1 Acute Myeloid Leukemia
                               5.6.1.1.1 Acute Myeloid Leukemia Market, 2016 To 2027 (USD Million)
                           5.6.1.2 Acute Lymphocytic Leukemia
                               5.6.1.2.1 Acute Lymphocytic Leukemia Market, 2016 To 2027 (USD Million)
                           5.6.1.3 Chronic Lymphocytic Leukemia
                               5.6.1.3.1 Chronic Lymphocytic Leukemia Market, 2016 To 2027 (USD Million)
                           5.6.1.4 Chronic Myeloid Leukemia
                               5.6.1.4.1 Chronic Myeloid Leukemia Market, 2016 To 2027 (USD Million)
                   5.7 Lymphoma
                       5.7.1 Lymphoma Market, 2016 To 2027 (USD Million)
                           5.7.1.1 Non-Hodgkin Lymphoma
                               5.7.1.1.1 Non-Hodgkin Lymphoma Market, 2016 To 2027 (USD Million)
                           5.7.1.2 Hodgkin Lymphoma
                               5.7.1.2.1 Hodgkin Lymphoma Market, 2016 To 2027 (USD Million)
                   5.8 Myeloproliferative Neoplasms
                       5.8.1 Myeloproliferative Neoplasms Market, 2016 TO 2027 (USD Million)
                           5.8.1.1 Polycythemia vera
                               5.8.1.1.1 Polycythemia vera Market, 2016 to 2027 (USD Million)
                           5.8.1.2 Essential thrombocythemia
                               5.8.1.2.1 Essential thrombocythemia Market, 2016 to 2027 (USD Million)
                           5.8.1.3 Myelofibrosis
                               5.8.1.3.1 Myelofibrosis Market, 2016 to 2027 (USD Million)
                   5.9 Other Cancers
                       5.9.1 OTHER CANCERS MARKET, 2016 TO 2027 (USD Million)
Chapter 6 Hemato Oncology Testing Market: Product Estimates and Trend Analysis
                   6.1 Definition & Scope
                   6.2 Product Market Share Analysis, 2019 & 2027
                   6.3 Segment Dashboard
                   6.4 Global Hemato Oncology Testing Market, by Product, 2016 to 2027
                   6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
                   6.6 Assay Kits and Reagents
                       6.6.1 Assay Kits And Reagents Market, 2016 To 2027 (USD Million)
                   6.7 Services
                       6.7.1 Services Market, 2016 To 2027 (USD Million)
Chapter 7 Hemato Oncology Testing Market: Technology Estimates and Trend Analysis
                   7.1 Definition & Scope
                   7.2 Technology Market Share Analysis, 2019 & 2027
                   7.3 Segment Dashboard
                   7.4 Global Hemato Oncology Testing Market, by Technology, 2016 to 2027
                   7.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
                   7.6 PCR
                       7.6.1 PCR MARKET, 2016 TO 2027 (USD Million)
                           7.6.1.1 Real-time qPCR
                               7.6.1.1.1 Real-time qPCR Market, 2016 to 2027 (USD Million)
                           7.6.1.2 Digital PCR
                               7.6.1.2.1 Digital PCR Market, 2016 to 2027 (USD Million)
                   7.7 IHC
                       7.7.1 IHC MARKET, 2016 TO 2027 (USD Million)
                   7.8 NGS
                       7.8.1 NGS MARKET, 2016 TO 2027 (USD Million)
                   7.9 Cytogenetics
                       7.9.1 CYTOGENETICS MARKET, 2016 TO 2027 (USD Million)
                   7.10 Other Technologies
                       7.10.1 OTHER TECHNOLOGIES MARKET, 2016 TO 2027 (USD Million)
Chapter 8 Hemato Oncology Testing Market: End Use Estimates and Trend Analysis
                   8.1 Definition & Scope
                   8.2 End Use Market Share Analysis, 2019 & 2027
                   8.3 Segment Dashboard
                   8.4 Global Hemato Oncology Testing Market, by End Use, 2016 to 2027
                   8.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
                   8.6 Hospitals
                       8.6.1 Hospitals Market, 2016 TO 2027 (USD Million)
                   8.7 Academic & Research Institutes
                       8.7.1 Academic & Research Institutes Market, 2016 TO 2027 (USD Million)
                   8.8 Others
                       8.8.1 Others Market, 2016 TO 2027 (USD Million)
Chapter 9 Hemato Oncology Testing Market: Regional Estimates & Trend Analysis
                   9.1 Regional Market Snapshot
                   9.2 Market Share Analysis by Country, 2019
                       9.2.1 NORTH AMERICA
                           9.2.1.1 U.S.
                           9.2.1.2 Canada
                       9.2.2 EUROPE
                           9.2.2.1 U.K.
                           9.2.2.2 Germany
                           9.2.2.3 Spain
                           9.2.2.4 France
                           9.2.2.5 Italy
                           9.2.2.6 Russia
                       9.2.3 LATIN AMERICA
                           9.2.3.1 Brazil
                           9.2.3.2 Mexico
                           9.2.3.3 Argentina
                       9.2.4 ASIA PACIFIC
                           9.2.4.1 Japan
                           9.2.4.2 China
                           9.2.4.3 India
                           9.2.4.4 South Korea
                           9.2.4.5 Australia
                           9.2.4.6 Singapore
                       9.2.5 MIDDLE EAST & AFRICA
                           9.2.5.1 South Africa
                           9.2.5.2 Saudi Arabia
                           9.2.5.3 UAE
                   9.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
                       9.3.1 NORTH AMERICA
                       9.3.2 EUROPE
                       9.3.3 LATIN AMERICA
                       9.3.4 ASIA PACIFIC
                       9.3.5 MIDDLE EAST & AFRICA
                   9.4 Market Size & Forecasts, and Trend Analysis, 2016 to 2027
                       9.4.1 NORTH AMERICA
                           9.4.1.1 North America Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
                           9.4.1.2 U.S.
                               9.4.1.2.1 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.1.2.2 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.1.2.3 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.1.2.4 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.1.3 Canada
                               9.4.1.3.1 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.1.3.2 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.1.3.3 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.1.3.4 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                       9.4.2 EUROPE
                           9.4.2.1 Europe Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
                           9.4.2.2 U.K.
                               9.4.2.2.1 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.2.2.2 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.2.2.3 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.2.2.4 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.2.3 Germany
                               9.4.2.3.1 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.2.3.2 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.2.3.3 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.2.3.4 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.2.4 France
                               9.4.2.4.1 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.2.4.2 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.2.4.3 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.2.4.4 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.2.5 Italy
                               9.4.2.5.1 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.2.5.2 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.2.5.3 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.2.5.4 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.2.6 Spain
                               9.4.2.6.1 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.2.6.2 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.2.6.3 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.2.6.4 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.2.7 Russia
                               9.4.2.7.1 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.2.7.2 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.2.7.3 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.2.7.4 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                       9.4.3 ASIA PACIFIC
                           9.4.3.1 Asia Pacific Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
                           9.4.3.2 Japan
                               9.4.3.2.1 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.3.2.2 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.3.2.3 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.3.2.4 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.3.3 China
                               9.4.3.3.1 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.3.3.2 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.3.3.3 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.3.3.4 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.3.4 India
                               9.4.3.4.1 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.3.4.2 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.3.4.3 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.3.4.4 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.3.5 South Korea
                               9.4.3.5.1 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.3.5.2 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.3.5.3 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.3.5.4 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.3.6 Australia
                               9.4.3.6.1 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.3.6.2 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.3.6.3 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.3.6.4 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.3.7 Singapore
                               9.4.3.7.1 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.3.7.2 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.3.7.3 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.3.7.4 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                       9.4.4 LATIN AMERICA
                           9.4.4.1 Latin America Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
                           9.4.4.2 Brazil
                               9.4.4.2.1 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.4.2.2 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.4.2.3 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.4.2.4 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.4.3 Mexico
                               9.4.4.3.1 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.4.3.2 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.4.3.3 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.4.3.4 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.4.4 Argentina
                               9.4.4.4.1 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.4.4.2 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.4.4.3 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.4.4.4 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                       9.4.5 MIDDLE EAST & AFRICA
                           9.4.5.1 Middle East & Africa Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
                           9.4.5.2 South Africa
                               9.4.5.2.1 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.5.2.2 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.5.2.3 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.5.2.4 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.5.3 Saudi Arabia
                               9.4.5.3.1 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.5.3.2 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.5.3.3 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.5.3.4 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
                           9.4.5.4 UAE
                               9.4.5.4.1 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
                               9.4.5.4.2 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
                               9.4.5.4.3 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
                               9.4.5.4.4 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
Chapter 10 COMPANY PROFILES
                   10.1 Company Profiles
                       10.1.1 F. HOFFMAN-LA ROCHE LTD.
                           10.1.1.1 Company overview
                           10.1.1.2 Financial performance
                           10.1.1.3 Product benchmarking
                           10.1.1.4 Strategic initiatives
                       10.1.2 ABBOTT LABORATORIES
                           10.1.2.1 Company overview
                           10.1.2.2 Financial performance
                           10.1.2.3 Product benchmarking
                           10.1.2.4 Strategic initiatives
                       10.1.3 QIAGEN N.V.
                           10.1.3.1 Company overview
                           10.1.3.2 Financial performance
                           10.1.3.3 Product benchmarking
                           10.1.3.4 Strategic initiatives
                       10.1.4 THERMO FISHER SCIENTIFIC, INC.
                           10.1.4.1 Company overview
                           10.1.4.2 Financial performance
                           10.1.4.3 Product benchmarking
                           10.1.4.4 Strategic initiatives
                       10.1.5 ILLUMINA, INC.
                           10.1.5.1 Company overview
                           10.1.5.2 Financial performance
                           10.1.5.3 Product benchmarking
                           10.1.5.4 Strategic initiatives
                       10.1.6 BIO-RAD LABORATORIES, INC.
                           10.1.6.1 Company overview
                           10.1.6.2 Financial performance
                           10.1.6.3 Product benchmarking
                           10.1.6.4 Strategic initiatives
                       10.1.7 MOLECULARMD
                           10.1.7.1 Company overview
                           10.1.7.2 Financial performance
                           10.1.7.3 Product benchmarking
                           10.1.7.4 Strategic initiatives
                       10.1.8 ARCHERDX, INC.
                           10.1.8.1 Company overview
                           10.1.8.2 Financial performance
                           10.1.8.3 Product benchmarking
                           10.1.8.4 Strategic initiatives
                       10.1.9 ARUP LABORATORIES INC.
                           10.1.9.1 Company overview
                           10.1.9.2 Financial performance
                           10.1.9.3 Product benchmarking
                           10.1.9.4 Strategic initiatives
                       10.1.10 ASURAGEN, INC.
                           10.1.10.1 Company overview
                           10.1.10.2 Financial performance
                           10.1.10.3 Product benchmarking
                           10.1.10.4 Strategic initiatives
                       10.1.11 INVIVOSCRIBE, INC.
                           10.1.11.1 Company overview
                           10.1.11.2 Financial performance
                           10.1.11.3 Product benchmarking
                           10.1.11.4 Strategic initiatives
                       10.1.12 ADAPTIVE BIOTECHNOLOGIES
                           10.1.12.1 Company overview
                           10.1.12.2 Financial performance
                           10.1.12.3 Product benchmarking
                           10.1.12.4 Strategic initiatives
                       10.1.13 CEPHEID
                           10.1.13.1 Company overview
                           10.1.13.2 Financial performance
                           10.1.13.3 Product benchmarking
                           10.1.13.4 Strategic initiatives
                       10.1.14 ENTROGEN, INC.
                           10.1.14.1 Company overview
                           10.1.14.2 Financial performance
                           10.1.14.3 Product benchmarking
                           10.1.14.4 Strategic initiatives
                       10.1.15 AMOY DIAGNOSTICS CO., LTD
                           10.1.15.1 Company overview
                           10.1.15.2 Financial performance
                           10.1.15.3 Product benchmarking
                           10.1.15.4 Strategic initiatives


List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies/product disruptors/innovators
Table 3 North America Hemato Oncology Testing Market, by countries, 2016 - 2027 (USD Million)
Table 4 North America Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 5 North America Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 6 North America Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 7 North America Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 8 U.S. Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 9 U.S. Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 10 U.S. Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 11 U.S. Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 12 Canada Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 13 Canada Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 14 Canada Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 15 Canada Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 16 Europe Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 17 Europe Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 18 Europe Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 19 Europe Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 20 U.K. Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 21 U.K. Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 22 U.K. Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 23 U.K. Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 24 Germany Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 25 Germany Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 26 Germany Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 27 Germany Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 28 France Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 29 France Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 30 France Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 31 France Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 32 Italy Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 33 Italy Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 34 Italy Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 35 Italy Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 36 Spain Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 37 Spain Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 38 Spain Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 39 Spain Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 40 Russia Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 41 Russia Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 42 Russia Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 43 Russia Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 44 Asia Pacific Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 45 Asia Pacific Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 46 Asia Pacific Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 47 Asia Pacific Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 48 Japan Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 49 Japan Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 50 Japan Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 51 Japan Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 52 China Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 53 China Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 54 China Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 55 India Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 56 India Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 57 India Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 58 India Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 59 South Korea Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 60 South Korea Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 61 South Korea Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 62 South Korea Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 63 Australia Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 64 Australia Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 65 Australia Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 66 Australia Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 67 Singapore Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 68 Singapore Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 69 Singapore Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 70 Singapore Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 71 Latin America Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 72 Latin America Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 73 Latin America Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 74 Latin America Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 75 Brazil Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 76 Brazil Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 77 Brazil Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 78 Brazil Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 79 Mexico Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 80 Mexico Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 81 Mexico Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 82 Mexico Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 83 Argentina Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 84 Argentina Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 85 Argentina Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 86 Argentina Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 87 MEA Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 88 MEA Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 89 MEA Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 90 MEA Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 91 South Africa Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 92 South Africa Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 93 South Africa Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 94 South Africa Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 95 Saudi Arabia Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 96 Saudi Arabia Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 97 Saudi Arabia Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 98 Saudi Arabia Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 99 UAE Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 100 UAE Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 101 UAE Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 102 UAE Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)


List of Figures

Fig. 1 Hemato Oncology Testing Market Segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 Hemato Oncology Testing Market Snapshot (2019)
Fig. 8 Hemato Oncology Testing Market: Segment Snapshot (2019)
Fig. 9 Competitive Insights (2019)
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Hemato Oncology Testing Market: Driver Impact
Fig. 15 Hemato Oncology Testing Market: Restraint Impact
Fig. 16 Hemato Oncology Testing Market: Opportunities Impact
Fig. 17 Hemato Oncology Testing Market: Challenges Impact
Fig. 18 Porter’s Five Forces Analysis
Fig. 19 SWOT Analysis, By Factor (Political & Legal, Economic and technological)
Fig. 20 Strategic alliance analysis
Fig. 21 Recent developments & impact analysis, by key market participants
Fig. 22 Key company market share analysis, 2019
Fig. 23 Company market share/ranking, by region
Fig. 24 Company market position analysis
Fig. 25 Cancer type market share analysis, 2019 & 2027
Fig. 26 Segment dashboard
Fig. 27 Global Hemato Oncology Testing Market, by Cancer Type, 2016 - 2027 (USD Million)
Fig. 28 Global Leukemia Market, 2016 - 2027 (USD Million)
Fig. 29 Global Acute Myeloid Leukemia Market, 2016 - 2027 (USD Million)
Fig. 30 Global Acute Lymphocytic Leukemia Market, 2016 - 2027 (USD Million)
Fig. 31 Global Chronic Lymphocytic Leukemia Market, 2016 - 2027 (USD Million)
Fig. 32 Global Chronic Myeloid Leukemia Market, 2016 - 2027 (USD Million)
Fig. 33 Global Lymphoma Market, 2016 - 2027 (USD Million)
Fig. 34 Global Non-Hodgkin Lymphoma Market, 2016 - 2027 (USD Million)
Fig. 35 Global Hodgkin Lymphoma Market, 2016 - 2027 (USD Million)
Fig. 36 Global Myeloproliferative Neoplasms Market, 2016 - 2027 (USD Million)
Fig. 37 Global Polycythemia vera Market, 2016 - 2027 (USD Million)
Fig. 38 Global Essential thrombocythemia Market, 2016 - 2027 (USD Million)
Fig. 39 Global Myelofibrosis Market, 2016 - 2027 (USD Million)
Fig. 40 Global Others Cancers Market, 2016 - 2027 (USD Million)
Fig. 41 Global Hemato Oncology Testing Market, by Product, 2016 - 2027 (USD Million)
Fig. 42 Global Assay Kits and Reagents Market, 2016 - 2027 (USD Million)
Fig. 43 Global Services Market, 2016 - 2027 (USD Million)
Fig. 44 Global Hemato Oncology Testing Market, by Technology, 2016 - 2027 (USD Million)
Fig. 45 Global PCR Market, 2016 - 2027 (USD Million)
Fig. 46 Global Real-time qPCR Market, 2016 - 2027 (USD Million)
Fig. 47 Global Digital PCR Market, 2016 - 2027 (USD Million)
Fig. 48 Global IHC Market, 2016 - 2027 (USD Million)
Fig. 49 Global NGS Market, 2016 - 2027 (USD Million)
Fig. 50 Global Cytogenetics Market, 2016 - 2027 (USD Million)
Fig. 51 Global Others Technologies Market, 2016 - 2027 (USD Million)
Fig. 52 Global Hemato Oncology Testing Market, by End-Use, 2016 - 2027 (USD Million)
Fig. 53 Global Hospitals Market, 2016 - 2027 (USD Million)
Fig. 54 Global Academic & Research Institutes Market, 2016 - 2027 (USD Million)
Fig. 55 Global Others Market, 2016 - 2027 (USD Million)
Fig. 56 Hemato Oncology Testing Market Snapshot
Fig. 57 North America Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 58 Europe Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 59 Asia Pacific Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 60 Latin America Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 61 Middle East and Africa Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 62 North America SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 63 Europe SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 64 Asia Pacific SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 65 Latin America SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 66 Middle East and Africa SWOT Analysis, by factor (political & legal, economic and technological)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.